1. Andriole, G. L., Teller, W. B., Coplen, D. E., Catalona, W. J.: PSA index (PSAI) as a predictor of prostate cancer (CaP) in men with persistent serum PSA elevation.J. Urol., 149, 387 (1993).
2. Benson, M. C., Whang, J. S., Olsson, G. A., McMakon, D. J., Conner, W. H.: The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen.J. Urol., 147, 817 (1992).
3. Carter, H. B., Morell, C. H., Pearson, J. D., Brant, L. J., Plato, C. C., Metter, F. J., Chan, D. W., Fozard, J. L., Walsh, P. C.: Estimation of prostatic growth using serial prostate-specific antigen measurements in men with and without prostate disease.Cancer Res., 52, 3323 (1981).
4. Chu, T. M., Murphy, G. P.: What's new in tumor markers for prostatic cancer.Urology, 27, 487 (1986).
5. Collins, G. N., Lee, R. J., McKelvie, G. B., Rogers, A. C., Hehir, M.: Relationship between prostate specific antigen, prostate volume and age in the benign prostate,Br. J. Urol., 71, 455 (1993).